ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,846, issued on Nov. 25, was assigned to PHARMABLOCK SCIENCES (NANJING) INC. (Jiangsu, China).
"EZH2 inhibitor and use thereof" was invented by Jin Li (Jiangbei New Area Nanjing, China), Hongdao Chen (Jiangbei New Area Nanjing, China), Liu Liu (Jiangbei New Area Nanjing, China) and Minmin Yang (Jiangbei New Area Nanjing, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present application provides a compound represented by formula (I), or a pharmaceutically acceptable salt, ester, prodrug, complex, solvate, hydrate, or isomer thereof; and a use thereof in preparing drugs used to treat EZH2-mediated disease."
The patent was filed on May 7, 20...